Home > Cluster Organisations > LYONBIOPOLE

LYONBIOPOLE

Primary tabs

Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Thursday, 24 November, 2005
Number of staff in the management team of the cluster organisation : 
11-20
Legal form of the cluster organisation: 
Registered Association
Regions: 
Rhône-Alpes
Cluster Excellence Label: 
Gold Label
Membership to European Strategic Cluster Partnerships (ESCP-4i, ESCP-S3 or ESCP-4x): 
bioXclusters plus
MAGIA
MAGIA2Market
S3martMed
Membership to other networks/partnerships: 
NameWebsite
CEBR
http://www.lifescience-cluster-innovations.space/
Cluster Management Team: 
NameSurnamePositionTelephoneEmailGender
Florence
AGOSTINO-ETCHETTO
Cluster Manager
0033472765330
info@lyonbiopole.com
Female
Kevin
ROMANI
Internationalisation Responsible
0033472765330
kevin.romani@lyonbiopole.com
Male
Emilie
ROMEO
ECCP Responsible Person
0033472765330
emilie.romeo@lyonbiopole.com
Emilien
VOLDOIRE
ECCP Responsible Person
0033472765330
emilien.voldoire@lyonbiopole.com
Male
Link to team description on the cluster's website: 
http://lyonbiopole.com/en/lyonbiopole/lyonbiopole-team
Languages spoken: 
English
French
Italian
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Technology fields: 
Cellular and Molecular Biology
Health information management
S3 EU priority areas: 
e-Health (e.g. healthy ageing)
Human health activities (medical services)
Emerging industries: 
Biopharmaceuticals
Digital Industries
Composition of the cluster
Total number of members: 
245
Number of SME members: 
220
Number of larger company members: 
6
Number of research organisations/universities/technology centres: 
19
Number of other ecosystem actors : 
50
Link to the cluster members’ list: 
http://lyonbiopole.com/communaute/annuaires/annuaire-entreprises-des-sciences-de-la-vie-en-rhone-alpes
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Name and link of major players: 
NameWebsiteType
SANOFI PASTEUR
http://www.sanofipasteur.com/fr/
Larger Company
BIOMERIEUX
http://www.biomerieux.fr/
Larger Company
Boehringer Ingelheim
https://www.boehringer-ingelheim.fr/bi-france/notre-implantation
Larger Company
BECTON DICKINSON
http://www.bd.com/fr/
Larger Company
MERCK
http://www.merckserono.fr/fr/index.html
Larger Company
CELLIPSE
http://http://cellipse.com/
SME
ELDERIS
http://www.edelris.com/
SME
ADOCIA
http://www.adocia.fr/WP/
SME
Université de Grenoble
http://www.univ-grenoble-alpes.fr/
University
Université de Lyon
http://www.universite-lyon.fr/
University
CEA
http://portail.cea.fr/Pages/le-cea/les-centres-cea/grenoble.aspx
Research Organisation
BIOASTER
http://www.bioaster.org/
Technology Center
Cluster Strategy
Mission/Objectives: 

As a biocluster, Lyonbiopole is the one-stop shop for healthcare innovation in Auvergne Rhône-Alpes Region, France. It aims to support the emergence and development of innovative technologies, products and services in 4 main strategic areas: human medicine, veterinary medicine, in vitro diagnostics, medical devices and medical technologies. Focused on infectious diseases since its creation in 2005, Lyonbiopole is now supporting ambitious projects and companies in other fields like cancer, nutrition, metabolic diseases and neurosciences. In 2020, Lyonbiopole represented a community of  245 members: 6 world-class leaders (Sanofi Pasteur, bioMérieux, Boehringer Ingelheim, BD, Merck) – 19 Research Centers including 3 Hospital University Centers and almost 220 SMEs. Since 2015, Lyonbiopole has been certified by the Gold label awarded by the "European Cluster Excellence Initiative".

Its main missions are to: 

  • Stimulate innovation (offering network and partnership opportunities)
  • Support SMEs development (access to private funds, business support...) 
  • Strengthen the cluster's international position
  • Develop a high-level infrastructure offer (proposing fully equipped platform of excellence (BSL2/BSL3 Labs, dedicated biomanufacturing & bioanalyses facilities, etc.).

More information: www.lyonbiopole.com

 

Do you have a formalised strategy?: 
Yes
Do you have a specific strategy focus that addresses internationalisation ?: 
Yes
Services
Support services provided: 
Access to the European Internal market
Internationalisation support (= Access to third countries markets)
Access to private funding (connecting to investors, seed-capital, venture-capital, crowd-funding, etc.)
Facilitation of collaboration between members
Enabling Facilities sharing
Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
Brazil
China
Japan
United States
Our cluster organisation undertook the following international activities to support our members: 
Participation at missions/events/study visits/fairs
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
Belgium
Germany
Italy
Spain
Sweden
Our cluster organisation undertook the following trans-national activities to support our members: 
Participation at missions/events/study visits/fairs
Please explain: 

- Organisation of trade missions, visits and B2B meetings in European regions in collaboration with European cluster partners - Organisation of Welcoming missions in Auvergne Rhone-Alpes region - Organisation of European Brokerage events in collaboration with Health NCP and clusters

Support Programmes
Participation in Funded Support Programmes: 
European ProgrammesProject Name
FP7
CIP/COSME
EIT KICs

CASYM - FP7 Coordination support action on System Medicine (partner)

ASSET - FP7 Coordination support action on "Action plan on Science in Society related issues in Epidemics and Total pandemics" (partner)

Health2CARE - CIP project for Cluster supporting Emerging industries / Regional cross cluster alliance on Personalised Medicine (partner)

KIC EIT Health (Associate Partner)

BioXclusters Plus - European Strategic Cluster Partnership on Personalised Healthcare - COSME co-funded project (coordinator)

 
 
 
Promotion
Success Story / Achievements: 
  • Lyonbiopole has built up and manages the Clinical Innovation programme encouraging collaboration between the 3 University Hospitals of Rhône-Alpes region and SMEs.
  • Lyonbiopole is the founding organisation of the ambitious programme of “Technological Research Institute” (TRI) BIOASTER that was selected in 2011, by the French government in the framework of the investments for the future programme. The TRI BIOASTER is focused on Infectious Diseases and it gathers Lyonbiopole, Institut Pasteur and 3 industrials (Sanofi, Institut Mérieux, Danone Research), 3 research bodies (INSERM, CNRS, CEA) and more than 50 SMBs from Lyon and Paris. www.bioaster.org
  • Lyonbiopole has developed access to equipped platform of excellence such as the Infectious Diseases Center (22,000 sq.ft. of BSL 2/3 labs)
  • Lyonbiopole is the coordinator of the bioXclusters+ initiative, launched in January 2016 co-funded by the EASME Agency.